 Weight Loss
"Weight Loss" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Decrease in existing BODY WEIGHT.
| Descriptor ID |
D015431
|
| MeSH Number(s) |
C23.888.144.243.963 G07.345.249.314.120.200.963
|
| Concept/Terms |
Weight Loss- Weight Loss
- Loss, Weight
- Losses, Weight
- Weight Losses
- Weight Reduction
- Reduction, Weight
- Reductions, Weight
- Weight Reductions
|
Below are MeSH descriptors whose meaning is more general than "Weight Loss".
Below are MeSH descriptors whose meaning is more specific than "Weight Loss".
This graph shows the total number of publications written about "Weight Loss" by people in this website by year, and whether "Weight Loss" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 1996 | 3 | 0 | 3 | | 1997 | 0 | 2 | 2 | | 1998 | 0 | 2 | 2 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 1 | 1 | | 2001 | 1 | 2 | 3 | | 2002 | 4 | 3 | 7 | | 2003 | 3 | 1 | 4 | | 2004 | 6 | 8 | 14 | | 2005 | 7 | 4 | 11 | | 2006 | 6 | 6 | 12 | | 2007 | 10 | 4 | 14 | | 2008 | 13 | 10 | 23 | | 2009 | 7 | 10 | 17 | | 2010 | 7 | 8 | 15 | | 2011 | 12 | 12 | 24 | | 2012 | 7 | 11 | 18 | | 2013 | 19 | 11 | 30 | | 2014 | 15 | 9 | 24 | | 2015 | 17 | 15 | 32 | | 2016 | 11 | 11 | 22 | | 2017 | 6 | 13 | 19 | | 2018 | 14 | 14 | 28 | | 2019 | 16 | 16 | 32 | | 2020 | 9 | 14 | 23 | | 2021 | 8 | 17 | 25 | | 2022 | 7 | 19 | 26 | | 2023 | 2 | 14 | 16 | | 2024 | 11 | 15 | 26 | | 2025 | 4 | 2 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Weight Loss" by people in Profiles.
-
Creasy SA, Ostendorf DM, Kaizer L, Rosenberg R, Breit MJ, Bessesen DH, Melanson EL, Catenacci VA. Effect of physical activity on changes in weight and aerobic capacity during an 18-month behavioral weight loss intervention. Int J Behav Nutr Phys Act. 2025 May 21; 22(1):57.
-
Catenacci VA, Ostendorf DM, Pan Z, Kaizer LK, Creasy SA, Zaman A, Caldwell AE, Dahle J, Swanson B, Breit MJ, Bing K, Wayland LT, Panter SL, Scorsone JJ, Bessesen DH, MacLean P, Melanson EL. The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months : A Randomized Clinical Trial. Ann Intern Med. 2025 May; 178(5):634-644.
-
Ryan M, Megyeri S, Nuffer W, Trujillo JM. The potential role of GLP-1 receptor agonists in osteoarthritis. Pharmacotherapy. 2025 Mar; 45(3):177-186.
-
Oldenburg N, Mashek DG, Harnack L, Wang Q, Manoogian ENC, Evanoff N, Dengel DR, Taddese A, Yentzer BP, Lysne L, Wong A, Hanson M, Anderson JD, Alvear A, LaPage N, Ryder J, Varady K, Gao Z, Ryu S, Bolan PJ, Bergman B, Helgeson E, Panda S, Chow LS. Time-restricted eating, caloric reduction, and unrestricted eating effects on weight and metabolism: a randomized trial. Obesity (Silver Spring). 2025 Apr; 33(4):671-684.
-
Ard JD, Ryan DH, O'Neil PM, Kushner RF, Wyatt HR, Bays HE, Greenway FL, Jakicic JM, Leonard S, Kenan Y, Ganon-Elazar E, Wadden TA. Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study. Obesity (Silver Spring). 2025 Mar; 33(3):500-511.
-
Snell-Bergeon JK, Kaur G, Renner D, Akturk HK, Beatson C, Garg SK. Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes. Diabetes Technol Ther. 2025 Jan; 27(1):1-9.
-
Cook TM, Fuller KNZ, Sandoval DA. Insights into the neurobiology of weight loss after bariatric surgery and GLP-1R agonists. Neuropharmacology. 2025 Mar 01; 265:110269.
-
Broussard JL, Garfield A, Zarini S, Brozinick JT, Perreault L, Newsom SA, Kahn D, Kerege A, Berry KZ, Bui HH, Bergman BC. Combined diet and exercise training decreases serum lipids associated with insulin resistance. Obesity (Silver Spring). 2024 Dec; 32(12):2334-2344.
-
Joseph S, Rwigema JC, Anderson D, Ishi S, Crafts T, Kuchta K, Denham W, Linn J, Hedberg HM, Ujiki MB. Loop duodenal switch confers more complications with little gain of weight loss compared to Roux-en-Y gastric bypass. Surg Endosc. 2025 02; 39(2):1261-1268.
-
Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, Bunck MC, Ahmad NN, Jouravskaya I. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025 Mar 06; 392(10):958-971.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|